Pharmaceuticals (NASDAQ: ARNA ) saw a nice week over week gain on the heels of a more robust advertising campaign. According to IMS Health , script sales this week were about 11,900 which represents a gain of 2.8% over last weeks numbers. While a 2
been cleared by the FDA via ANDAs or NDAs prior to their discontinuation or withdrawal from the market. According to IMS Health , the U.S. addressable market for the products is ~$200M. Almost half of the 18 drugs are on the FDA shortage list
By Dallas Salazar : Five months ago when IMS Health Holdings, Inc. (NYSE: IMS ) held its IPO I opined that the company should be purchased in Core Position quantity. Now, for
generic version of Sunovion Pharmaceuticals' Xopenex (levalbuterol hydrochloride) inhalation solution. According to IMS Health , the U.S. market is ~$270M. Post your comment!
Lannett Company (NYSE: LCI ) commences shipping its recently-approved oxycodone hydrochloride oral solution USP, 100 mg/5 mL. The U.S. wholesale market is ~43M per IMS Health . The company reaffirms its fiscal 2015 guidance. Post your comment!
this week due to the Labor Day holiday. Sales were down 12% from last week's numbers according to industry source IMS Health . While seeing sales dip is never a positive, the news was essentially expected and the stock price did not carry an
antiretroviral therapies upon which around 40% of HIV/AIDS patients in developing countries depend. According to IMS Health , Mylan currently has 294 abbreviated new drug applications pending for FDA approval which represent $105.7 billion
equivalent of Lehigh Valley Technologies' Oxycodone Hydrochloride Oral Solution USP, 100 mg/5 mL. According the IMS Health , the U.S. wholesale market is ~$43M per year. Post your comment!
escrow pending the satisfaction of certain conditions. Aspen will supply Arixtra and its generic to Mylan. According to IMS Health , U.S. sales of branded Arixtra were $18.8M for the 12-month period ending June 30, 2014. Generic Arixtra sales
pill Belviq from Arena Pharmaceuticals (NASDAQ: ARNA ) were up modestly this past week, according to industry tracker IMS Health . Total sales were a bit over 11,400 scripts, and the percentage gain from last week was about 1.4%. New scripts